Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03264183 · ClinicalTrials.gov registry record
Validating TEE Measurements of Right Ventricular Function
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 126
- Enrollment target
NCT03264183: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT03264183 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03264183 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
Transesophageal echocardiography (TEE) is becoming a more prevalent method of monitoring and diagnosis in the perioperative setting for critically ill patients and patients undergoing cardiac surgery. Many TEE measurements are extrapolated from transthoracic echocardiography (TTE) data and have not validated by transesophageal means. The aim of this study is to validate TEE assessment of right ventricular function by comparing them to simultaneously measured TTE measurements. Likewise, there are currently no agreed upon values for RV free wall strain. Therefore, the investigators will attempt to define a range of normal values of RV free wall strain as compared to the other measures of RV function.
Primary Outcome
Right ventricular index of myocardial performance (RIMP) will be measured using both TTE and TEE.
Interventions
- DIAGNOSTIC_TEST Transesophageal Echocardiography
- DIAGNOSTIC_TEST Transthoracic Echocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2018-10-10 |
What the finished NCT03264183 record still lists
NCT03264183 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Transesophageal Echocardiography is the first listed.
NCT03264183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03264183 about?
NCT03264183 is a clinical study titled "Validating TEE Measurements of Right Ventricular Function". Transesophageal echocardiography (TEE) is becoming a more prevalent method of monitoring and diagnosis in the perioperative setting for critically ill patients and patients undergoing cardiac surgery. Many TEE measurements are extrapolated from transthoracic echocardiography (TTE) data and have not ...
What is the current status of trial NCT03264183?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2017-09-18. Estimated completion is 2018-10-10.
What interventions are being tested in trial NCT03264183?
The interventions under investigation include: Transesophageal Echocardiography (DIAGNOSTIC_TEST), Transthoracic Echocardiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03264183?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI